CoreFirst Bank & Trust
- SEC CIK
- 0001845199
- Latest filing
- Aug 5, 2026
PFE holding history
Pfizer Inc in every 13F filed by CoreFirst Bank & Trust, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,811
- Value
- $91.8K
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,811 | $91.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 3,811 | $107.0K | 0.1% | −686−15.3% | Reduced | Holders |
| Q4 2025 | 4,497 | $112.0K | 0.1% | −1,500−25.0% | Reduced | Holders |
| Q3 2025 | 5,997 | $152.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 5,997 | $145.4K | 0.1% | +5,997 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −8,534−100.0% | Sold out | Holders |
| Q4 2024 | 8,534 | $226.4K | 0.1% | −900−9.5% | Reduced | Holders |
| Q3 2024 | 9,434 | $273.0K | 0.2% | −327−3.4% | Reduced | Holders |
| Q2 2024 | 9,761 | $273.1K | 0.2% | −19,122−66.2% | Reduced | Holders |
| Q1 2024 | 28,883 | $801.5K | 0.5% | −13,273−31.5% | Reduced | Holders |
| Q4 2023 | 42,156 | $1.21M | 0.8% | −1,011−2.3% | Reduced | Holders |
| Q3 2023 | 43,167 | $1.43M | 1.0% | +1,966+4.8% | Added | Holders |
| Q2 2023 | 41,201 | $1.51M | 1.1% | −2,326−5.3% | Reduced | Holders |
| Q1 2023 | 43,527 | $1.78M | 1.3% | −1,380−3.1% | Reduced | Holders |
| Q4 2022 | 44,907 | $2.30M | 1.7% | +108+0.2% | Added | Holders |
| Q3 2022 | 44,799 | $1.96M | 1.7% | −550−1.2% | Reduced | Holders |
| Q2 2022 | 45,349 | $2.38M | 1.9% | +265+0.6% | Added | Holders |
| Q1 2022 | 45,084 | $2.33M | 1.6% | −349−0.8% | Reduced | Holders |
| Q4 2021 | 45,433 | $2.68M | 1.7% | 00.0% | Unchanged | Holders |
| Q3 2021 | 45,433 | $1.96M | 1.4% | +683+1.5% | Added | Holders |
| Q2 2021 | 44,750 | $1.75M | 1.2% | −683−1.5% | Reduced | Holders |
| Q1 2021 | 45,433 | $1.65M | 1.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.